Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07485595 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Name: A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression — clinical trial record (NCT07485595)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2/3

SponsorTasly Pharmaceutical Group Co., Ltd

Started2026-04-30

View on ClinicalTrials.gov ↗

Amendment history

2026-04-02

Study Status, Outcome Measures v1

Secondary endpointsdetails revised at 3 of 11 entries

2026-03-16

Original filing

Tasly Pharmaceutical Group Co., Ltd

19 trials monitored

See 1 trial at risk

Depression

2,976 trials monitored

See 162 trials at risk

The purpose of this study is to evaluate the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Trial Details

NCT Number	NCT07485595
Lead Sponsor	Tasly Pharmaceutical Group Co., Ltd
Conditions	Depression
Enrollment	180 participants
Start Date	2026-04-30
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-08